The FDA approved Adamas Pharmaceuticals Inc’s treatment for a side effect caused by a commonly prescribed Parkinson’s drug.
Ohio’s Department of Insurance said non-profit managed care company CareSource will sell health plans in Paulding County in 2018 – the last county in the United States that would have been without Obamacare individual coverage during the year.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for Pharmacoepidemiology (ISPE) announced their plans for a one-day conference focused on real-world evidence.
Novel Gene Therapy Shows Three-Fold Improvement in Recurrence-Free Survival in High-Risk, Early-Stage Bladder Cancer Patients Where Current Gold-Standard Treatment Fails
The Society of Urologic Oncology and the Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) announced that the Journal of Clinical Oncology published results from a Phase II clinical study led by the SUO-CTC demonstrating the potential effectiveness of Instiladrin (rAD-IFN/Syn3) in patients with high grade, BCG refractory or relapsed Non-Muscle Invasive Bladder Cancer.
Financial concerns continue to plague ImmunoCellular Therapeutics as the company continues to look for cost-cutting measures that will provide enough resources to fund continued R&D on the company’s Stem-to-T-Cell research program.
AstraZeneca’s blood-thinner Brilinta cuts the risk of cardiovascular death by 29 percent in patients with a history of past heart attacks who keep taking it beyond the standard 12-month initial period, according to new clinical trial data.
Novartis AG’s Kisqali (ribociclib) received European Union approval as first-line treatment for a tough-to-treat breast cancer.
Swiss pharma group Roche said the U.S. Food and Drug Administration granted priority review to its emicizumab for hemophilia A with inhibitors.
GSW, an INC Research/inVentiv Health company and industry leader in healthcare advertising, named Sonja Foster-Storch as President. Foster-Storch reports to Lisa Stockman, President of inVentiv Health Communications.
Hearing impairment is already linked to a heightened risk of cognitive decline in old age, and a new study suggests that impaired vision may carry the same risk.
Brain scans obtained during psychological stress might someday help doctors identify people who are at higher risk for heart disease, a new study suggests.
India’s plan to bring in marketing rules to curb unethical promotional practices in the country’s drug industry faces an indefinite delay after it hit a legal roadblock, marking a setback for public health groups.
IBM: Your Computer Can Help Scientists Study Connection Between Body Bacteria and Autoimmune Diseases
The general public’s help is being enlisted in what is believed to be the largest study of the human microbiome – the bacteria that live in and on the human body – and are believed to affect health.
A Phase 3 study evaluating Ultragenyx Pharmaceuticals’ aceneuramic acid extended release in patients with GNE Myopathy did not achieve its primary endpoint.
Shares of Paratek rocketed upward after the antibiotics specialist posted a “for sale” sign on the doors.
Anthem Reaches Goal Two Years Early for Health Plans to Reduce Opioids Filled at Pharmacy by 30 Percent
Anthem Inc. is committed to supporting policy changes that help reduce, prevent and deter opioid use disorder, as well as those that help consumers better access treatment. As part of that commitment, its affiliated health plans just reached the company’s collective goal of reducing prescribed opioids filled at pharmacies by 30 percent during the past five years.
Argentum Pharmaceuticals announced that it reached a settlement and license agreement with Eli Lilly related to Argentum’s generic version of Cialis (tadalifil).
New York Festivals Global Awards, honoring the World’s Best Healthcare & Wellness Advertising, announced the 2017 Executive and Grand Juries.
Eye doctors who had braced themselves for at least a few patients after a dazzling solar eclipse swept the United States cautiously exhaled, with some hospitals reporting zero cases of damaged vision so far.
India granted Pfizer Inc. a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.